An efficient procedure for the preparation of (1S,3R)- and (1S,3S)-1-amino-3-(hydroxymethyl)cyclopentanes

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 10, 2003, Pages 1153-1156

  Rapoport, Henry ^a   Chen, Yuewu ^a   Mohareb, Rafat M ^b   Ahn, Jin Hee ^c   Sim, Tae Bo ^d   Ho, Jonathan Z ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Genomics Institute of the Novartis Resarch   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Amino acid; Carbocycle; Enantioselectivity; Heterocycle; Nucleoside

Indexed keywords

1 AMINO 3 (HYDROXYMETHYL)CYCLOPENTANE; ASPARTIC ACID; CYCLOPENTANE DERIVATIVE; NUCLEOSIDE ANALOG; RIBOSE; UNCLASSIFIED DRUG; AMINOALCOHOL;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENANTIOMER; STEREOISOMERISM; SYNTHESIS;

AMINO ALCOHOLS; CYCLOPENTANES; STEREOISOMERISM;

EID: 2442516290     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.1153     Document Type: Article

References (21)

1. Recent reviews on carbocyclic nucleosides (carbanucleosides) see: Schneller S. W., Curr. Top. Med. Chem. (Hilversum, Neth.), 2, 1086-1092 (2002).
2. Ferrier R. J., Blattner R., Field R. A., Furneaux R. H., Gardiner J. M., Hoberg J. O., Kartha K. P. R., Tilbrook D. M. G., Tyler P. C., Wightman R. H., Carbohydr. Chem., 33, 275-333 (2002).
3. Marquez V. E., Adv. Antiviral Drug Des., 2, 89-146 (1996).
4. Zhu X.-F., Nucleosides, Nucleotides & Nucleic Acids, 19, 651-690 (2000).
5. Agrofoglio L., Suhas E., Farese A., Condom R., Challand S. R., Earl R. A., Guedj R., Tetrahedron, 50, 10611-10670 (1994).
6. Store R., Baxter A. D., Boehme R. E., Clemens I. R., Hart G. J., Jones M. F., Marr Clara L. P., Mason Andrew M., Mo C. L., Special Pub.-Royal Soc. Chem., 119 (Recent Adv. Chem. Anti-Infective Agents), 251-265 (1993).
7. Marques V. E., Lim M., Med. Res. Rev., 6, 1-40 (1986).
8. Fort S. M., Potter B. V. L., Tetrahedron Lett., 38, 5371-5374 (1997).
9. Sharkin Y., Collect. Czech. Chem. Commun., 61, S171-S173 (1996).
10. Lee-Ruff E., Xi F., Qie J. H., J. Org. Chem., 61, 1547-1550 (1996).
11. Vince R., Hua M., J. Med. Chem., 33, 17-21 (1990).
12. Shealy Y. F., O'Dell C. A., Thorpe M. C., J. Heterocycl. Chem., 18, 383-389 (1981).
13. Beres J., Sagi G., Tomoskozi I., Gruber L., Gulacsi E., Otvos L., Tetrahedron Lett., 29, 2681-2684 (1988).
14. Santan L., Teijeira M., Uriarte E., Teran C., Casellato U., Graziani R., Nucleosides Nucleotides, 15, 1179-1187 (1996).
15. Beres J., Sagi G., Tomoskozi I., Gruber L., Baitz-Gacs E., Otvos L., Clercq E. D., J. Med, Chem., 33, 1353-1360 (1990).
16. Daluge S. M., PCT Int. Appl., 1991, WO 9100282 A1. 1-38.
17. Sicsic S., Durand P., Langrene S., Le Goffic F., Eur. J. Biochem., 155, 403-407 (1986).
18. Bergmeier S. C., Cobas A. A., Rapoport H., J. Org. Chem., 58, 2369-2376 (1993).
19. Bergmeier S. C., Lee W. K., Rapoport H., J. Org. Chem., 58, 5019-5022 (1993).
20. Ho J. Z., Mohareb R. M., Ahn J. H., Sim T. B., Rapoport H., J. Org. Chem., 68, 109-114 (2003).
21. Ho J. Z., Mohareb R. M., Ahn J. H., Sim T. B., Rapoport H., Abstracts of papers, 225 National Meeting of the American Chemical Society, New Orleans, LA, March 23-27, 2003, ORGN-537.